STAAR Surgical urges shareholders to approve Alcon's $30.75 per share offer

Go back to STAAR Surgical urges shareholders to approve Alcon's $30.75 per share offer

STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

December 17, 2025 10:55 AM EST

Broadwood Has Consistently Misled STAAR Stockholders About Takeover Interest in STAAR In Order to Derail the Alcon Merger

STAAR Urges Stockholders to Vote FOR the Alcon Transaction on WHITE Proxy Card TODAY

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today issued the following open letter to STAAR stockholders:

Dear STAAR Surgical Stockholders:

The Special Meeting of... More